Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Can the Best-Selling Drugs of 2021 Repeat Their Performance?
05:43am, Sunday, 05'th Jun 2022
These were the industry's bestsellers last year, but how long can they stay on top?
5 Safe And Cheap Dividend Stocks To Invest In (June 2022)
01:30pm, Saturday, 04'th Jun 2022 Seeking Alpha
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms.
Merck (MRK) Stock Moves -0.1%: What You Should Know
09:45pm, Friday, 03'rd Jun 2022 Zacks Investment Research
In the latest trading session, Merck (MRK) closed at $89.91, marking a -0.1% move from the previous day.
Regeneron (REGN) to Buy Sanofi's Stake in Libtayo, Stock Down
07:42pm, Friday, 03'rd Jun 2022 Zacks Investment Research
Regeneron (REGN) will obtain global rights to Libtayo from Sanofi in exchange for an upfront payment of $900 million and royalties.
Why Pfizer Needs a High-Growth Pipeline
11:54am, Friday, 03'rd Jun 2022 The Motley Fool
The company moves to build a solid lineup to replace COVID-19 revenue that just can't last.
The 3 Best Long-Term Stocks to Add to Your Q2 Buy List
06:45am, Friday, 03'rd Jun 2022
Recent declines on Wall Street create the perfect opportunity to invest in these three best long-term stocks. The post The 3 Best Long-Term Stocks to Add to Your Q2 Buy List appeared first on Investor
7 Stocks to Buy and Hold Forever in This Bear Market
06:23am, Wednesday, 01'st Jun 2022
Dump speculative, over-priced stocks and buy strong businesses during a bear market because good investments will reward investors. The post 7 Stocks to Buy and Hold Forever in This Bear Market appear
Real Estate Trends for Investors to Watch
10:45pm, Tuesday, 31'st May 2022 The Motley Fool
We've got interviews with the CEOs of RE/MAX and Alexandria Real Estate Equities.
Merck: Still Undervalued After 22% Return
05:30pm, Tuesday, 31'st May 2022
Merck, currently priced at about 12.5x FW PE, is still undervalued by a sizable margin. Growth from pipeline drugs and especially Molnupiravir is not properly priced in, leading to a PEG ratio of only
Don't fall in love with stocks, they'll break your heart
02:10pm, Tuesday, 31'st May 2022 MarketWatch
Sexy stocks may bring an initial thrill, but when it comes to investing, boring is usually best.
The Zacks Analyst Blog Highlights AstraZeneca, Merck, Roche, J&J, and Pfizer
01:39pm, Tuesday, 31'st May 2022 Zacks Investment Research
AstraZeneca, Merck, Roche, J&J, and Pfizer are part of Zacks top Analyst Blog
7 Highest-Yielding Goldman Sachs Conviction List Stocks Can Thrive in a Recession
07:35am, Tuesday, 31'st May 2022
Last week's final reading of a negative 1.5% gross domestic product for the first quarter (the first such print since the second quarter of 2020) was even worse than the preliminary reading, and it is
Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
07:03pm, Monday, 30'th May 2022 Zacks Investment Research
Bristol Myers (BMY) secures an FDA approval for two Opdivo-based regimens as the first-line treatment of unresectable advanced or metastatic esophageal squamous cell carcinoma.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
01:50pm, Monday, 30'th May 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Iovance (IOVA) Down After Announcing Data From Melanoma Study
06:43pm, Friday, 27'th May 2022 Zacks Investment Research
Results from a cohort of the phase II study evaluating Iovance's (IOVA) melanoma candidate were not as superior as data from another cohort of the same study.
